Related Experiment Video
Updated: Mar 3, 2026

07:11
Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
Published on: May 25, 2020
6.9K
No differences in central corneal thickness between open-angle and pseudoexfoliation glaucoma patients
Marcelo Ayala1, Johanna Karlsson2
1Eye Department, Skaraborg Hospital, Skövde, Sahlgrenska Academy, Gothenburg University and Karolinska Institute.
Clinical Ophthalmology (Auckland, N.Z.)
|May 2, 2017
Summary
Central corneal thickness (CCT) was similar in patients with primary open-angle glaucoma (POAG) and exfoliation glaucoma (XFG). This finding suggests corneal thickness does not explain differing glaucoma progression rates between these conditions.
Area of Science:
- Ophthalmology
- Glaucoma Research
- Corneal Physiology
Background:
- Intraocular pressure (IOP) measurements using Goldmann applanation tonometry are influenced by central corneal thickness (CCT).
- Thinner corneas can lead to underestimation, while thicker corneas can lead to overestimation of true IOP.
- Existing literature presents conflicting data on CCT in primary open-angle glaucoma (POAG) and exfoliation glaucoma (XFG) patients.
Purpose of the Study:
- To investigate and compare central corneal thickness (CCT) in patients diagnosed with exfoliation glaucoma (XFG) and primary open-angle glaucoma (POAG).
- To determine if differences in CCT could explain the varying progression rates observed between XFG and POAG.
Main Methods:
- Central corneal thickness (CCT) was measured using optical coherence tomography (OCT).
- Participants diagnosed with POAG or XFG underwent comprehensive ophthalmological examinations.
- Exclusion criteria included contact lens use and pre-existing corneal diseases.
Main Results:
- A total of 145 patients were included in the study.
- The mean CCT was comparable between the POAG group (535±30.4 µm) and the XFG group (536±33.7 µm), with no statistically significant difference (P=0.98).
- Demographic data were similar between groups, with mean deviation being the only statistically significant differing parameter (P=0.02).
Conclusions:
- Patients with exfoliation glaucoma (XFG) do not exhibit thinner central corneal thickness compared to those with primary open-angle glaucoma (POAG).
- Central corneal thickness (CCT) is unlikely to be the sole factor explaining the differential progression rates observed between XFG and POAG.
Keywords:
central corneal thicknessexfoliative glaucomaoptical coherence tomographyprimary open-angle glaucomaMore Related Videos
Related Concept Videos
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Glaucoma: Overview
1.6K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.6K
Angle Closure Glaucoma: Treatment
1.5K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.5K

